These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23903573)

  • 21. Recognition of tumor-associated antigens by T lymphocytes: from basic concepts to new approaches.
    Cerottini JC; von Fliedner V; Boon T
    Ann Oncol; 1992 Jan; 3(1):11-6. PubMed ID: 1606063
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunotherapy: personalizing tumour vaccines.
    Killock D
    Nat Rev Clin Oncol; 2015 Feb; 12(2):64. PubMed ID: 25511189
    [No Abstract]   [Full Text] [Related]  

  • 23. From cancer genomics to cancer immunotherapy: toward second-generation tumor antigens.
    Schultze JL; Vonderheide RH
    Trends Immunol; 2001 Sep; 22(9):516-23. PubMed ID: 11525943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the genes encoding cancer antigens: implications for cancer immunotherapy.
    Rosenberg SA; Kawakami Y; Robbins PF; Wang R
    Adv Cancer Res; 1996; 70():145-77. PubMed ID: 8902056
    [No Abstract]   [Full Text] [Related]  

  • 25. Prospects for adoptive T cell therapy.
    Yee C; Riddell SR; Greenberg PD
    Curr Opin Immunol; 1997 Oct; 9(5):702-8. PubMed ID: 9368780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The function of tumor specific antigen (MAGE) in tumor immunotherapy].
    Fang JB; Wang L
    Sheng Li Ke Xue Jin Zhan; 2005 Jul; 36(3):273-5. PubMed ID: 16270835
    [No Abstract]   [Full Text] [Related]  

  • 27. Genes coding for tumor rejection antigens: perspectives for specific immunotherapy.
    Boon T; Coulie P; Marchand M; Weynants P; Wölfel T; Brichard V
    Important Adv Oncol; 1994; ():53-69. PubMed ID: 8206495
    [No Abstract]   [Full Text] [Related]  

  • 28. Defining tumor antigens: mRNA, protein or cytotoxicity?
    Lim SH; Periman P; Klug P; Weidanz J; Whitton V; Chiriva-Internati M; Wang Z; Wright S
    Trends Immunol; 2002 May; 23(5):236-7; author reply 237-8. PubMed ID: 12102740
    [No Abstract]   [Full Text] [Related]  

  • 29. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy.
    Seremet T; Brasseur F; Coulie PG
    Cancer J; 2011; 17(5):325-30. PubMed ID: 21952282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a tumor associated antigen that can induce tumor specific cytotoxicity.
    Dunkle A; He YW
    Cancer Biol Ther; 2009 May; 8(9):844-5. PubMed ID: 19377280
    [No Abstract]   [Full Text] [Related]  

  • 31. [Identification of tumor antigens: strategies and perspectives].
    Zippelius A; Knights A; Tinguely M; Jäger D; Renner C; Knuth A
    Dtsch Med Wochenschr; 2006 Aug; 131(33):1809-12. PubMed ID: 16902905
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer neoantigen: Boosting immunotherapy.
    Xu P; Luo H; Kong Y; Lai WF; Cui L; Zhu X
    Biomed Pharmacother; 2020 Nov; 131():110640. PubMed ID: 32836075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oncogene-associated tumor antigens as targets for immunotherapy.
    Hellström KE; Hellström I
    FASEB J; 1989 Apr; 3(6):1715-22. PubMed ID: 2649402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calling cancer's bluff with neoantigen vaccines.
    DeWeerdt S
    Nature; 2017 Dec; 552(7685):S76-S77. PubMed ID: 29293229
    [No Abstract]   [Full Text] [Related]  

  • 35. Cancer/testis antigens, gametogenesis and cancer.
    Simpson AJ; Caballero OL; Jungbluth A; Chen YT; Old LJ
    Nat Rev Cancer; 2005 Aug; 5(8):615-25. PubMed ID: 16034368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of chaperones as essential components of the tumor rejection moieties of cancers.
    Srivastava PK
    Cancer Immun; 2012; 12():5. PubMed ID: 22896750
    [No Abstract]   [Full Text] [Related]  

  • 37. Dendritic cell therapy of cancer: can it fulfill its promise?
    Vermorken JB; Van Tendeloo VF
    Expert Rev Anticancer Ther; 2003 Feb; 3(1):1-3. PubMed ID: 12597344
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer vaccines: the state of the art.
    Finn OO; Banchereau J
    Semin Immunol; 2010 Jun; 22(3):103-4. PubMed ID: 20552730
    [No Abstract]   [Full Text] [Related]  

  • 39. In Silico Prediction of Tumor Neoantigens with TIminer.
    Kirchmair A; Finotello F
    Methods Mol Biol; 2020; 2120():129-145. PubMed ID: 32124316
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunology: new approaches to immuno-modulation and immunotherapy].
    Kabelitz D
    Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.